CoChat

A Randomized Porcine Study in Low Cardiac Output of Vasoactive and Inotropic Drug Effects on the Gastrointestinal Tract

Open access

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Background: Splanchnic vasodilation by inodilators is an argument for their use in critical cardiac dysfunction. To isolate peripheral vasoactivity from inotropy, such drugs were investigated, and contrasted to vasopressors, in a fixed low cardiac output (CO) model resembling acute cardiac dysfunction effects on the gastrointestinal tract. We hypothesized that inodilators would vasodilate and preserve the aerobic metabolism in the splanchnic circulation in low CO. Methods: In anesthetized pigs, CO was lowered to 60% of baseline by partial inferior caval vein balloon inflation. The animals were randomized to placebo (n = 8), levosimendan (24 μg kg−1 bolus, 0.2 μg kg−1 min−1, n = 7), milrinone (50 μg kg−1 bolus, 0.5 μg kg−1 min−1, n = 7), vasopressin (0.001, 0.002 and 0.006 U kg−1 min−1, 1 h each, n = 7) or norepinephrine (0.04, 0.12, and 0.36 μg kg−1 min−1, 1 h each, n = 7). Hemodynamic variables including mesenteric blood flow were collected. Systemic, mixed-venous, mesenteric-venous, and intraperitoneal metabolites were analyzed. Results: Cardiac output was stable at 60% in all groups, which resulted in systemic hypotension, low superior mesenteric artery blood flow, lactic acidosis, and increased intraperitoneal concentrations of lactate. Levosimendan and milrinone did not change any circulatory variables, but levosimendan increased blood lactate concentrations. Vasopressin and norepinephrine increased systemic and mesenteric vascular resistances at the highest dose. Vasopressin increased mesenteric resistance more than systemic, and the intraperitoneal lactate concentration and lactate/pyruvate ratio. Conclusion: Splanchnic vasodilation by levosimendan and milrinone may be negligible in low CO, thus rejecting the hypothesis. High-dose vasopressors may have side effects in the splanchnic circulation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/shk.0000000000001726

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Animal inclusion by randomization and animal exclusions in the different study groups.
Fig. 1 Animal inclusion by randomization and animal exclusions in the different study groups.CC BY-NC-ND · PubMed Central
Fig. 2 Cardiac indices in animals subjected to partial inflation of an occlusion balloon in the inferior caval vein immediately after time point 0 h. Starting at 1 h, the animals were randomized to intravenous infusion of either placebo (5% glucose, 0.2 mL kg−1 h−1), vasopressin (0.001 U kg−1 min−1 for the first hour, 0.002 U kg−1 min−1 for the second hour, and 0.006 U kg−1 min−1 for the last hour), norepinephrine (0.04 μg kg−1 min−1 for the first hour, 0.12 μg kg−1 min−1 for the second hour, and 0.36 μg kg−1 min−1 for the last hour), levosimendan (bolus 24 μg kg−1 in 10 min, thereafter continuous infusion of 0.2 μg kg−1 min−1) or milrinone (bolus 50 μg kg−1 in 10 min, thereafter continuous infusion of 0.5 μg kg−1 min−1). Data are presented as means and 95% confidence intervals. See Figure 1 for the exact number of animals in each group at each time point.
Fig. 2 Cardiac indices in animals subjected to partial inflation of an occlusion balloon in the inferior caval vein immediately after time point 0 h. Starting at 1 h, the animals were randomized to intravenous infusion of either placebo (5% glucose, 0.2 mL kg−1 h−1), vasopressin (0.001 U kg−1 min−1 for the first hour, 0.002 U kg−1 min−1 for the second hour, and 0.006 U kg−1 min−1 for the last hour), norepinephrine (0.04 μg kg−1 min−1 for the first hour, 0.12 μg kg−1 min−1 for the second hour, and 0.36 μg kg−1 min−1 for the last hour), levosimendan (bolus 24 μg kg−1 in 10 min, thereafter continuous infusion of 0.2 μg kg−1 min−1) or milrinone (bolus 50 μg kg−1 in 10 min, thereafter continuous infusion of 0.5 μg kg−1 min−1). Data are presented as means and 95% confidence intervals. See Figure 1 for the exact number of animals in each group at each time point.CC BY-NC-ND · PubMed Central
Fig. 3 Mean arterial pressure (MAP, panel A), mesenteric and systemic vascular resistance indices, and their ratio (MVRI, panel D; SVRI, panel B; MVRI/SVRI ratio, panel F), superior mesenteric artery blood flow (SMA flow, panel C), and heart rate (panel E) in animals subjected to partial inflation of an occlusion balloon in the inferior caval vein immediately after time point 0 h. Starting at 1 h, the animals were randomized to intravenous infusion of either placebo (5% glucose, 0.2 mL kg−1 h−1), levosimendan (bolus 24 μg kg−1 in 10 min, thereafter continuous infusion of 0.2 μg kg−1 min−1) or milrinone (bolus 50 μg kg−1 in 10 min, thereafter continuous infusion of 0.5 μg kg−1 min−1). a: statistical difference between the indicated time point and baseline in the placebo group. Data are presented as means and 95% confidence intervals. See Figure 1 for the exact number of animals in each group at each time point.
Fig. 3 Mean arterial pressure (MAP, panel A), mesenteric and systemic vascular resistance indices, and their ratio (MVRI, panel D; SVRI, panel B; MVRI/SVRI ratio, panel F), superior mesenteric artery blood flow (SMA flow, panel C), and heart rate (panel E) in animals subjected to partial inflation of an occlusion balloon in the inferior caval vein immediately after time point 0 h. Starting at 1 h, the animals were randomized to intravenous infusion of either placebo (5% glucose, 0.2 mL kg−1 h−1), levosimendan (bolus 24 μg kg−1 in 10 min, thereafter continuous infusion of 0.2 μg kg−1 min−1) or milrinone (bolus 50 μg kg−1 in 10 min, thereafter continuous infusion of 0.5 μg kg−1 min−1). a: statistical difference between the indicated time point and baseline in the placebo group. Data are presented as means and 95% confidence intervals. See Figure 1 for the exact number of animals in each group at each time point.CC BY-NC-ND · PubMed Central
Fig. 4 Mean arterial pressure (MAP, panel A), mesenteric and systemic vascular resistance indices, and their ratio (MVRI, panel D; SVRI, panel B; MVRI/SVRI ratio, panel F), superior mesenteric artery blood flow (SMA flow, panel C), and heart rate (panel E) in animals subjected to partial inflation of an occlusion balloon in the inferior caval vein immediately after time point 0 h. Starting at 1 h, the animals were randomized to intravenous infusion of either placebo (5% glucose, 0.2 mL kg−1 h−1), vasopressin (0.001 U kg−1 min−1 for the first hour, 0.002 U kg−1 min−1 for the second hour, and 0.006 U kg−1 min−1 for the last hour) or norepinephrine (0.04 μg kg−1 min−1 for the first hour, 0.12 μg kg−1 min−1 for the second hour, and 0.36 μg kg−1 min−1 for the last hour). a: statistical difference between the indicated time point and baseline in the placebo group. b and c: statistical difference between the norepinephrine or vasopressin and placebo group, respectively, at the indicated time points. Data are presented as means and 95% confidence intervals. See Figure 1 for the exact number of animals in each group at each time point.
Fig. 4 Mean arterial pressure (MAP, panel A), mesenteric and systemic vascular resistance indices, and their ratio (MVRI, panel D; SVRI, panel B; MVRI/SVRI ratio, panel F), superior mesenteric artery blood flow (SMA flow, panel C), and heart rate (panel E) in animals subjected to partial inflation of an occlusion balloon in the inferior caval vein immediately after time point 0 h. Starting at 1 h, the animals were randomized to intravenous infusion of either placebo (5% glucose, 0.2 mL kg−1 h−1), vasopressin (0.001 U kg−1 min−1 for the first hour, 0.002 U kg−1 min−1 for the second hour, and 0.006 U kg−1 min−1 for the last hour) or norepinephrine (0.04 μg kg−1 min−1 for the first hour, 0.12 μg kg−1 min−1 for the second hour, and 0.36 μg kg−1 min−1 for the last hour). a: statistical difference between the indicated time point and baseline in the placebo group. b and c: statistical difference between the norepinephrine or vasopressin and placebo group, respectively, at the indicated time points. Data are presented as means and 95% confidence intervals. See Figure 1 for the exact number of animals in each group at each time point.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Research works printed but not linked: 1

  1. 2010, Anonymous: Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes, Official J Eur Union, L276, 33

Cited by

See all 10

Metadata

Authors
Seilitz, J., Grafver, I., Kiszakiewicz, L., Oikonomakis, I., Jansson, K., Axelsson, B., & Nilsson, K. F.
Affiliations
  • Örebro University (SE)
  • Skaraborg Hospital (SE)
Corresponding author
  • Seilitz, Jenny
  • Grafver, Isabelle
  • Axelsson, Birger
  • Nilsson, Kristofer F.
Venue
Shock
Published
2021-01-13
Volume
56
Issue
2
Pages
308-317
ISSN
  • 1073-2322 (ISSN-L)
  • 1540-0514
OpenAlex
W3118352087
Cited by
10
References
45
Citations by year
2026: 2 · 2025: 1 · 2024: 3 · 2022: 3 · 2021: 1
FWCI
1.64
Type
journal article
Language
en
Open access
Locations
  • Shock (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Keywords
low cardiac output, splanchnic vasodilation, inodilators, levosimendan, milrinone, vasopressors, norepinephrine, vasopressin, gastrointestinal metabolism, mesenteric blood flow, lactate, lactic acidosis, lactate/pyruvate ratio, cardiac dysfunction, splanchnic circulation
MeSH terms
Simendan, Animals, Cardiac Output, Low, Disease Models, Animal, Female, Male, Norepinephrine, Random Allocation, Splanchnic Circulation, Swine, Vasodilator Agents, Vasopressins, Milrinone, Gastrointestinal Tract

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Randomized Porcine Study in Low Cardiac Output of Vasoactive and Inotropic Drug Effects on the Gastrointestinal Tract. https://app.cochat.ai/papers/10.1097/shk.0000000000001726
The paper
Seilitz, J., Grafver, I., Kiszakiewicz, L., Oikonomakis, I., Jansson, K., Axelsson, B., & Nilsson, K. F. (2021). A Randomized Porcine Study in Low Cardiac Output of Vasoactive and Inotropic Drug Effects on the Gastrointestinal Tract. Shock. https://doi.org/10.1097/shk.0000000000001726

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.